Portfolio company
TRICUSPID VALVE REPAIR
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Versa Vascular develops a transcatheter tricuspid valve repair system for patients suffering from tricuspid regurgitation to restore heart function without requiring open-heart surgery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
TRiCares
This company develops a catheter-based tricuspid valve replacement system for patients suffering from tricuspid regurgitation.
Valcare Medical
The company develops transcatheter repair and replacement technologies for heart valves to treat patients with mitral and tricuspid regurgitation.
CroiValve
The company develops a transcatheter heart valve system to treat tricuspid regurgitation in patients unsuitable for open-heart surgery.
Meacor
Meacor develops a catheter-based medical device for repairing heart valves to treat patients with mitral and tricuspid regurgitation without undergoing open-heart surgery.
Coramaze
This medical technology company develops a transcatheter valve repair system for treating patients with tricuspid regurgitation and other structural heart conditions.
CroíValve
The company develops a minimally invasive transcatheter valve system to treat tricuspid regurgitation for elderly and frail cardiac patients.
HVR Cardio
This company develops transcatheter mitral valve repair devices to treat patients with mitral regurgitation.
CardioMech
CardioMech develops a transcatheter-based artificial chordae delivery system for hospitals to treat patients suffering from degenerative mitral regurgitation without open-heart surgery.